Prognosis of Recurrence after Complete Resection in Early-Stage Non-Small Cell Lung Cancer

다국어 초록 (Multilingual Abstract)

Background: Tumor recurrence is the most common cause of treatment failure, even after complete resection of early-stage non-small cell lung cancer (NSCLC). In this study, we investigated the prognosis of patients with early recurrence in order to identify independent risk factors related to early recurrence. Methods: Between February 1995 and December 2012, 242 patients who underwent surgical resection for stage I NSCLC at Dong-A University Hospital were reviewed. The factors predicting overall survival (OS) and early recurrence were investigated. We also investigated the relationship between the patterns and period of recurrence and clinicopathological factors. Results: For patients with stage IA and IB NSCLC, the 5-year OS rate was 75.7% and 57.3% (p=0.006), respectively. A multivariate Cox proportional hazards model demonstrated that gender (p=0.004), comorbidity number (p=0.038), resection type (p=0.002), and tumor size (p=0.022) were the statistically significant predictors of OS. Moreover, the multivariate analysis revealed that smoking history (p=0.023) and histologic grade (p=0.012) were the independent predictors of early recurrence. Additionally, only histologic grade (poor differentiation) was found to be significantly associated with a higher frequency of distant metastasis; there was no relationship between the patterns and period of recurrence and clinicopathological factors. Conclusion: The present study demonstrated that smoking history and histologic grade were independent prognostic factors for early recurrence within two years in patients with early-stage NSCLC. Patients with these predictive factors may be good candidates for adjuvant therapy.

참고문헌 (Reference)

1 Sugimura H, "Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection" 83 : 409-417, 2007

2 Jones DR, "Stage IB nonsmall cell lung cancers: are they all the same?" 81 : 1958-1962, 2006

3 Dominioni L, "Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening" 89 (89): 2334-2344, 2000

4 Harpole DH Jr, "Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence" 76 : 787-796, 1995

5 Goodgame B, "Recent advances in lung cancer: summary of presentations from the 45th annual meeting of the American Society of Clinical Oncology (2009)" 4 : 1293-1300, 2009

6 Martini N, "Prospective study of 445 lung carcinomas with mediastinal lymph node metastases" 80 : 390-399, 1980

7 Brundage MD, "Prognostic factors in non-small cell lung cancer: a decade of progress" 122 : 1037-1057, 2002

8 Pairolero PC, "Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease" 38 : 331-338, 1984

9 Nakagawa T, "Postrecurrence survival in patients with stage I non-small cell lung cancer" 34 : 499-504, 2008

10 Hung JJ, "Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence" 64 : 192-196, 2009

11 Maeda R, "Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification" 139 : 855-861, 2011

12 Pignon JP, "Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group" 26 : 3552-3559, 2008

13 Martini N, "Incidence of local recurrence and second primary tumors in resected stage I lung cancer" 109 : 120-129, 1995

14 Thomas P, "Cancer recurrence after resection: T1 N0 non-small cell lung cancer" Lung Cancer Study Group 49 : 242-246, 1990

15 Pollack JR, "A perspective on DNA microarrays in pathology research and practice" 171 : 375-385, 2007